- Patent Title: B7H4-targeted antibody-drug conjugates and methods of use thereof
-
Application No.: US17568376Application Date: 2022-01-04
-
Publication No.: US11964024B2Publication Date: 2024-04-23
- Inventor: Timothy B. Lowinger , Chen-Ni Chin , Marc I. Damelin , Dorin Toader
- Applicant: Mersana Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Mersana Therapeutics, Inc.
- Current Assignee: Mersana Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: COOLEY LLP
- Agent Cynthia A. Kozakiewicz; Ivor Elrifi
- Main IPC: A61K47/68
- IPC: A61K47/68 ; A61K39/395 ; A61P35/00 ; C07K16/28 ; C07K16/30 ; C07K16/32
Abstract:
The present disclosure relates generally to antibody-drug conjugates comprising monoclonal antibodies that specifically bind the human B7-H4 in soluble form, or membrane bound (i.e., when expressed on a cell surface) and to methods of using these conjugates as therapeutics and/or diagnostics.
Public/Granted literature
- US20220233707A1 B7H4-TARGETED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF Public/Granted day:2022-07-28
Information query
IPC分类:
